Biomotion Sciences Ordina...

1.30
0.72 (124.14%)
At close: Jan 28, 2025, 3:06 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22
Net Income -5.11M -3.49M
Depreciation & Amortization 45.00K 57.00K
Stock-Based Compensation 130.00K 125.00K
Other Working Capital -10.00K 317.00K
Other Non-Cash Items 317.00K -268.00K
Deferred Income Tax n/a n/a
Change in Working Capital 87.00K 239.00K
Operating Cash Flow -4.53M -3.33M
Capital Expenditures -12.00K -40.00K
Acquisitions n/a n/a
Purchase of Investments n/a -500.00K
Sales Maturities Of Investments 507.00K 16.00K
Other Investing Acitivies 78.00K n/a
Investing Cash Flow 573.00K -524.00K
Debt Repayment n/a n/a
Common Stock Repurchased n/a n/a
Dividend Paid n/a n/a
Other Financial Acitivies 522.00K 2.75M
Financial Cash Flow 522.00K 2.75M
Net Cash Flow -3.66M -1.77M
Free Cash Flow -4.54M -3.38M